High-Dose Vitamin D 3 for Critically Ill Vitamin D–Deficient Patients
Authors:
- 23 April 2020
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 382 (17) , 1669-1671
Abstract
To the Editor: The National Heart, Lung, and Blood Institute PETAL (Prevention and Early Treatment of Acute Lung Injury) Clinical Trials Network (Dec. 26 issue)1 conducted a placebo-controlled trial of early vitamin D3 supplementation in critically ill vitamin D–deficient patients at high risk for death (Vitamin D to Improve Outcomes by Leveraging Early Treatment [VIOLET] trial). The plasma concentration of total 25-hydroxyvitamin D is currently used as an indicator of vitamin D status. However, there has been debate about whether measurement of total 25-hydroxyvitamin D is appropriate for the assessment of vitamin D status in certain clinical situations.2 Serum 25-hydroxyvitamin . . .Keywords
This publication has 11 references indexed in Scilit:
- Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study)BMJ Open, 2019
- Vitamin D deficiency and its treatment in cystic fibrosisJournal of Cystic Fibrosis, 2019
- Vitamin D Binding Protein and 25-Hydroxyvitamin D Levels: Emerging Clinical ApplicationsEndocrine Practice, 2017
- Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in SepsisCritical Care Medicine, 2015
- Effect of High-Dose Vitamin D3on Hospital Length of Stay in Critically Ill Patients With Vitamin D DeficiencyJAMA, 2014
- Vitamin D: a negative acute phase reactantJournal of Clinical Pathology, 2013
- Vitamin D in sepsis: from basic science to clinical impactCritical Care, 2012
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2011
- Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot studyCritical Care, 2011
- Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D3Journal of Cystic Fibrosis, 2007